#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15742	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2081	750.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1693	1693	T	815	T,C	753,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15742	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2081	750.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1427	1427	C	949	C,A,T	870,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28216	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3540	794.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1681	1681	A	984	A	907	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28216	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3540	794.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2315	2315	C	897	C	835	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28216	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3540	794.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2389	2389	A	884	A	827	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28216	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3540	794.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2941	2941	C	871	C,T,A	804,5,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2122	folP	855	855	100.0	folP.l15.c4.ctg.1	1617	130.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1012	1014	AGC	241;237;236	A;G;C	223;220;217	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5420	gyrA	2751	2751	99.96	gyrA.l6.c17.ctg.1	3370	160.3	1	SNP	p	S91F	1	.	.	271	273	TTC	597	599	TTC	184;186;186	T;T;C	173;176;174	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5420	gyrA	2751	2751	99.96	gyrA.l6.c17.ctg.1	3370	160.3	1	SNP	p	D95G	1	.	.	283	285	GGC	609	611	GGC	193;193;198	G,A;G;C	184,1;185;184	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5420	gyrA	2751	2751	99.96	gyrA.l6.c17.ctg.1	3370	160.3	1	SNP	p	G95N	0	.	.	283	285	GGC	609	611	GGC	193;193;198	G,A;G;C	184,1;185;184	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1750	mtrR	633	633	98.89	mtrR.l15.c4.ctg.1	1271	137.0	0	.	p	.	0	D79N	NONSYN	235	237	GAT	528	530	AAT	233;230;227	A;A;T	218;217;217	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1750	mtrR	633	633	98.89	mtrR.l15.c4.ctg.1	1271	137.0	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	606	608	CAC	210;211;214	C;A;C	201;201;206	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1750	mtrR	633	633	98.89	mtrR.l15.c4.ctg.1	1271	137.0	1	SNP	p	G45D	0	.	.	133	135	GGC	426	428	GGC	251;251;252	G,T;G;C	226,1;228;228	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5034	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3036	165.4	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1539	1541	GTC	209;211;211	G;T;C	193;195;196	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5034	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3036	165.4	1	SNP	p	D86N	0	.	.	256	258	GAC	645	647	GAC	215;216;217	G;A;C	202;198;204	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5034	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3036	165.4	1	SNP	p	S87R	1	.	.	259	261	CGT	648	650	CGT	222;221;221	C;G;T	211;208;205	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5034	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3036	165.4	1	SNP	p	R87I	0	.	.	259	261	CGT	648	650	CGT	222;221;221	C;G;T	211;208;205	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5034	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3036	165.4	1	SNP	p	R87W	0	.	.	259	261	CGT	648	650	CGT	222;221;221	C;G;T	211;208;205	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5034	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3036	165.4	1	SNP	p	S88P	0	.	.	262	264	TCC	651	653	TCC	218;217;217	T;C;C	205;200;203	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4556	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2692	168.6	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1352	1354	TGC	228;228;229	T,C;G;C	202,1;206;207	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4556	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2692	168.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1562	1564	GGC	210;211;209	G,A;G,T;C	195,1;195,1;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4372	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2391	182.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1218	1220	GCA	250;247;253	G;C;A	225;227;235	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4372	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2391	182.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1221	1223	ATC	256;256;261	A,C;T;C	235,1;236;238	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4372	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2391	182.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1233	1235	GTG	262;261;263	G;T;G	237;234;237	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4372	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2391	182.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1233	1235	GTG	262;261;263	G;T;G	237;234;237	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4372	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2391	182.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1737	1739	ACC	222;224;225	A;C;C	205;210;210	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4372	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2391	182.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1791	1793	GCG	236;234;235	G,T;C;G	204,1;189;200	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4372	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2391	182.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1791	1793	GCG	236;234;235	G,T;C;G	204,1;189;200	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4372	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2391	182.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1914	1916	GGC	212;210;206	G;G;C	197;195;193	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4372	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2391	182.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1923	1925	GGC	213;212;210	G;G;C	200;197;197	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4372	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2391	182.1	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1941	1943	TCG	203;204;201	T,G;C;G	127,6;155;158	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6124	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3128	194.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1617	1619	CCG	241;240;237	C;CG,C;G	215;220,1;213	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2456	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1869	130.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	631	631	C	178	C	162	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3050	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1376	217.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	311	313	GAA	284;283;285	G;A;A,C	263;267;269,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3050	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1376	217.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	599	601	GAT	238;239;239	G;A;T	222;223;222	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3050	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1376	217.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	722	724	TCA	267;266;265	T;C;A	244;246;245	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3050	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1376	217.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	851	853	GTC	251;254;256	G;T;C	236;239;243	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3050	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1376	217.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1181	1183	GCA	174;174;172	G;C;A	163;162;162	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3050	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1376	217.9	0	.	p	.	0	D333V	NONSYN	997	999	GAC	1196	1198	GTC	156;153;154	G;T;C	147;143;146	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3050	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1376	217.9	1	SNP	p	G120K	1	.	.	358	360	AAG	557	559	AAG	250;246;244	A;A;G,A	235;232;229,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3050	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1376	217.9	1	SNP	p	A121D	1	.	.	361	363	GAC	560	562	GAC	244;239;242	G;A;C,A	226;222;225,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3050	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1376	217.9	1	SNP	p	D121N	0	.	.	361	363	GAC	560	562	GAC	244;239;242	G;A;C,A	226;222;225,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11552	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4986	231.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1974	1976	AAT	230;229;231	A;A;T	215;213;212	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1256	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1057	118.2	1	SNP	p	V57M	1	.	.	169	171	ATG	535	537	ATG	284;285;285	A;T;G	263;264;265	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
